相关实验视频

Updated: May 20, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

用JPH203准LAT1,通过阻止必需氨基酸的吸收来减少TNBC的扩散,并重塑抑制免疫的微环境

Yajie Zhao¹, Chunrui Pu¹, Kangdong Liu²

¹Department of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.

|May 16, 2025

概括

在三阴性乳腺癌 (TNBC) 中准必需氨基酸载体LAT1通过导致氨基酸饥饿来抑制瘤生长. 这种方法还重塑了瘤的免疫微环境,提高了免疫治疗的疗效.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

乳腺癌细胞的必需氨基酸 (EAA) 吸收会影响预后和免疫抑制.
L型氨基酸载体 (LAT1和LAT2) 调解EAA吸收,并在瘤中过度表达.
这些载体在不同乳腺癌亚型,特别是三阴性乳腺癌 (TNBC) 中的作用需要进一步研究.

研究的目的:

调查针对TNBC中的EAA传送器,特别是LAT1 (SLC7A5) 的治疗潜力.
探索LAT1在重塑瘤免疫微环境中的作用.
评估LAT1向作为TNBC组合免疫治疗的策略.

主要方法:

多omics数据分析以确定EAA载体分布跨乳腺癌亚型.
在体外实验中使用SLC7A5淘汰和LAT1抑制剂来评估对TNBC细胞增殖和EAA吸收的影响.
使用4T1-BALB/c小鼠模型进行体内研究,以评估LAT1向对瘤生长和免疫微环境的影响.

主要成果:

在EAA吸收方面,TNBC显著依赖LAT1.
准LAT1诱导氨基酸饥饿,细胞循环停止和TNBC细胞的亡.
在体内,LAT1抑制抑制了瘤生长,并重塑了免疫抑制性瘤微环境,改善了PD-1抗体的疗效.

结论:

LAT1是TNBC的一个有前途的治疗点.
准LAT1可以重塑瘤的免疫微环境,并与免疫疗法协同作用.
这一策略为TNBC的组合疗法提供了潜在的新途径.

关键词:

乳腺癌乳腺癌乳腺癌重要的氨基酸是必不可少的.免疫微环境是一个微环境.JPH203 是一个很棒的项目.

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.